Your browser doesn't support javascript.
loading
The history of respiratory disease management.
Geddes, Duncan.
Afiliación
  • Geddes D; is an Honorary Consultant at the Royal Brompton Hospital, London and Professor of Respiratory Medicine at Imperial College, London, UK. His main clinical and research interests are cystic fibrosis, lung cancer and emphysema. He was President of the British Thoracic Society and Chairman of Asthma UK. Competing interests: none declared.
Medicine (Abingdon) ; 44(6): 393-397, 2016 Jun.
Article en En | MEDLINE | ID: mdl-32288580
ABSTRACT
Lung diseases have shifted from infections - tuberculosis, pneumonia - to diseases of dirty air - chronic obstructive pulmonary disease, asthma and lung cancer. New diseases have emerged from industrial pollution and HIV, while better imaging has revealed others previously unrecognized. Scientific advances in microbiology, imaging and clinical measurement have improved diagnosis and allowed better targeted treatment. Advances in treatment have been dramatic, the most important being drugs (antibiotics, cortisone, ß2-adrenoreceptor agonists), ventilatory support (from iron lung to nasal positive-pressure ventilation), inhaled therapy (metered dose inhalers, nebulizers) and lung surgery (resections, video-assisted thoracoscopic surgery, transplantation). Delivery of care has shifted from sanatoria for the rich but nothing at all for the poor, to hospitals and universal coverage. Generalists have turned into super-specialists and doctors have been joined by growing numbers of professions allied to medicine (PAMs). Management of lung disease has vastly improved but the impact of disease remains.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Medicine (Abingdon) Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Medicine (Abingdon) Año: 2016 Tipo del documento: Article